A fatal outbreak of hypervirulent Carbapenem-resistant Klebsiella pneumoniae has been reported in August’s edition of The Lancet Infectious Disease. This convergence of antibiotic resistance, hypervirulence and high transmission rate within a single strain led to 100% mortality rate in infected patients.
Welcome to the Bioquell Media/Press Centre. On our site you’ll find quick, easy access to Bioquell's technology and details of our global operations.
Be sure to check in regularly for the latest updates. And if you need more information, please contact Martin Whiting, Marketing Director and Press Communications on firstname.lastname@example.org or by telephone +44 (0)1264 835 835.
Complete press kits are available on request.
Bioquell welcomes clarification of biocide regulations by HSE
23 September 2016
Leading bio-decontamination experts Bioquell warmly welcomes the latest publication by the HSE highlighting the timescale for hydrogen peroxide-based biocides to be compliant.
Hypervirulent, antibiotic resistant Klebsiella found in China
Candida auris – spreading through UK hospitals
Candida auris is a multi-drug resistant yeast that was first discovered in the ear of a Japanese patient in 2009. The yeast can enter the bloodstream via catheters, lines or other tubes entering the body and spread through the body causing serious invasive infections.
UK investment into a promising new type of cancer treatment.
A large 30 million pound investment will be used to form a spin-out biopharma company called Autolus
US Company AMRI to acquire two manufacturing sites from pharmaceutical services company Aptuit.
In a $60 million deal Amri has bought Aptuit’s Glasgow aseptic manufacturing site plus its Indiana, US-based solid-state chemistry business.